Bertschi looks further afield

BEST SERVED CHILLED

TEMPERATURE • CSAFE GLOBAL HAS BEEN LISTENING TO CUSTOMER NEEDS AND, IN RESPONSE, HAS EXPANDED ITS ASIAN HUB AND DEVELOPED A NEW COLD CHAIN PACKAGING SOLUTION

THE ASIA-PACIFIC REGION has received a boost in pharmaceutical logistics and possibilities thanks to a recent facility expansion at Incheon Airport, South Korea, by CSafe Global. CSafe, a provider of active temperature-controlled container solutions for the transport of pharmaceuticals, invested in the facility to improve service levels and customer support for the transport of temperature-sensitive products to and from South Korea, while it also serves as an important gateway hub for the greater Asia-Pacific region.

Furthermore, at time of writing, CSafe is to reveal a new cold chain packaging solution

CSAFE’S NEW INCHEON SERVICE CENTRE PROVIDES

A GATEWAY TO NORTH-EAST ASIA for use with cells and genes at the Phacilitate Leaders World event in Miami. The CSafe Cell and Gene thermal shipping solution leverages the company’s industry-leading temperature management performance for the safe transport of vital life-science products to distribution centres, healthcare facilities and patients.

BIGGER POSSIBILITIES The Incheon site is one of the latest of numerous locations around the world established to broaden CSafe’s global service reach and increase the impact on customers who have entrusted CSafe containers to thermally protect vital life-enhancing pharmaceuticals.

Tom Weir, vice-president of global operations at CSafe, says: “We’re excited about our best-in-class service centre in Incheon. This new facility will ensure that our active containers are operating at top system performance, keeping temperatures precisely where they need to be for transports of crucial medications. Our service team has been trained and is well prepared to address the significant volume demand for CSafe RKN and CSafe RAP containers from the Incheon station.

“With the expanded warehouse space and increased repair service throughput, not only can we easily accommodate the increasing product demand from South Korea, but we also strengthen our ability to flex as needed for repositioning large numbers of our temperature-controlled containers to other CSafe hubs within Asia-Pacific to meet unexpected or immediate surge demand from our customers and partners across the region,” Weir continues.

To verify that CSafe RKN and CSafe RAP systems are providing the best quality and are operating optimally, all containers entering CSafe service centres are put through an industry-unique Preventative Maintenance Rebuild (PMR) programme.

While expanding the hub in South Korea, CSafe has been conversing with customers to better understand their needs and requirements, ultimately designing new solutions to problems that arise. “As partner to those in the most difficult portion of the cold chain, CSafe is committed to innovation, continuous improvement and unparalleled customer service. This is especially important for the cell and gene market given the critical nature of these shipments for patients in need,” explains Emilio Frattaruolo, vicepresident of innovation for passive solutions.

“We work closely with our customers and provide tailored solutions to meet their needs. For example, we are partnering with one biotech company that has chosen our innovative cell and gene solution to address the strict requirements for transporting their advanced gene therapy. My CSafe colleagues and I are personally committed to securing their cold chain, protecting these new gene therapy shipments so patients can receive what matters most to them. This is the kind of personalised experience we provide to our cell and gene customers.” csafeglobal.com